Call 800 665 0411 to learn about our services

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

PURA (OTC: $PURA) and KALY (OTC: $KALY) Announce Landing First Kenyan Coffee Shipment Adding to $8 Million 2020 Beverage Revenue Target


Dallas, Texas - December 3, 2019 (Newsfile Corp.) ( Newswire) Puration, Inc. (OTC Pink: PURA) today announced the company has landed its first Kenyan coffee shipment. The company recently announced it will begin producing CBD infused Fair Trade coffee from Kenya. Now that the first shipment from Kenya has arrived, the company can begin formulating the CBD infusion. PURA has engaged Kali-Extracts, Inc. (OTC: KALY) to design the CBD infusion for ground coffee. KALY has a U.S. Patented Cannabis Extraction Process. PURA has the sole license of the patent for beverage infusion.

PURA currently makes and sells EVERx CBD Sports Water, the leading CBD sports drink in the sports nutrition market. PURA has recently confirmed a $4 million 2020 revenue target following the publication of its Q3 financial report. The company has also confirmed an $8 million 2020 revenue target built on the growing sales of EVERx and the introduction of new cannabis infused beverages.

A few months ago, PURA launched an initiative to partner with other beverage companies and introduce CBD Infused beer, coffee and tea beverages. PURA recently introduced TranquiliTeaCBD as its first new beverage from the beer, coffee and tea initiative. TranquiliTea is expected to be on shelves before the end of the year.

As part of PURA's new beverage initiative, PURA engaged Goldman Small Cap Research to conduct a CBD beverage industry survey (see link below). Goldman has published the final survey results of the survey.

CBD Beverage Survey Highlights

"Key Numbers: When asked in order of preference what CBD-infused beverage they would buy, 77 or 31% said tea and 74 or 30% said water. As a provider of water and tea, PURA leadership certainly is providing consumers the most popular categories of CBD-infused beverages which bodes very well for future sales and market share growth."

"The Trend is PURA's Friend: While CBD oils remain the most popular source of CBD products, the data and responses indicate that oils, vapes, and tinctures usage may be swapped on an ever-increasing scale, for edibles and beverages. We expect that they will eventually overtake these product categories which will be a boon to PURA."

To see the full final CBD Beverage industry survey results, follow the link below:

CBD Beverage Industry Results

For more information on Puration, visit

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.


Puration, Inc.
Brian Shibley,
(800) 861-1350

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories for Cannabis stocks and Psychedelic Stocks

Buy a cannabis guest post on